
Science and Development Network
News, views and information about science, technology and the developing world
Source: Rediff.com
17 June 2004 | EN
The World Health Organisation (WHO) has removed two generic HIV drugs made in India from its list of medicines approved for use by United Nations agencies. It is the first time that drugs have been dropped from the approved list in this way.
The drugs — lamivudine (3TC) and zidovudine (AZT) — were found to have inadequate paperwork to prove they were biologically equivalent to the patented drugs.
Cipla, the Indian pharmaceutical firm that makes the two drugs expects them to be back on the approved list within coming weeks. And a WHO official has stated that he doesn't expect the problem to interfere with the organisation's plans to treat three million, mostly African, people with HIV by next year.
All comments are subject to approval and we reserve the right to edit comments containing inappropriate/unsuitable language. SciDev.Net holds copyright for all material posted on the website. Please see terms of use for further details.
All SciDev.Net material is free to reproduce providing that the source and author are appropriately credited. For further details see Creative Commons.
13 February 2012